Cidara is developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious fungal or viral infections.

Antifungal:
REZAFUNGIN

A next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections

Antiviral Platform:
CLOUDBREAK® AVCs

Long-lasting antiviral conjugates (AVCs) designed to directly inhibit viral proliferation while simultaneously engaging the immune system

Leading The Science of Protection

Cidara is developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious fungal or viral infections.

Antifungal:
REZAFUNGIN

A next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections

Antiviral Platform:
CLOUDBREAK® AVCs

Long-lasting antiviral conjugates (AVCs) designed to directly inhibit viral proliferation while simultaneously engaging the immune system

PIPELINE

RECENT NEWS